Home/Filings/4/0001209191-17-050387
4//SEC Filing

GOODWIN ROBERT ALLEN II 4

Accession 0001209191-17-050387

CIK 0000884624other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 4:27 PM ET

Size

8.3 KB

Accession

0001209191-17-050387

Insider Transaction Report

Form 4
Period: 2017-08-24
GOODWIN ROBERT ALLEN II
President Biologics
Transactions
  • Disposition to Issuer

    Common stock

    2017-08-24$48.29/sh6,205$299,65531,127 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.21 to $48.33, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

ORTHOFIX INTERNATIONAL N V

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001669838

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:27 PM ET
Size
8.3 KB